Literature DB >> 7665441

Prediction of clinical response to methylphenidate in children with attention-deficit hyperactivity disorder.

J K Buitelaar1, R J Van der Gaag, H Swaab-Barneveld, M Kuiper.   

Abstract

OBJECTIVE: To examine the pattern of individual responses to to methylphenidate (MPH) in children with attention-deficit hyperactivity disorder and to examine factors that predict drug response.
METHOD: Individual drug response was defined on the basis of changes on the Abbreviated Conners Rating Scales completed by parents and teachers. These scales were the main outcome measures in a double-blind, placebo-controlled trial of MPH. Response prediction was examined in stepwise discriminant analyses, in which baseline variables and the response to a single, 10-mg dose of MPH were entered.
RESULTS: Predictors of a strong MPH response were a high IQ, considerable inattentiveness, young age, low severity of disorder, and low rates of anxiety. A positive response to a single dose of MPH significantly improved the prediction of less stringently defined levels of MPH response.
CONCLUSION: Only strong levels of response could be predicted by baseline characteristics. Severity of disorder based on clinical judgment and improvement after a single dose of MPH are found to be important contributors to response prediction.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7665441     DOI: 10.1097/00004583-199508000-00012

Source DB:  PubMed          Journal:  J Am Acad Child Adolesc Psychiatry        ISSN: 0890-8567            Impact factor:   8.829


  28 in total

1.  Factors associated with response to methylphenidate in advanced cancer patients.

Authors:  Sriram Yennurajalingam; J Lynn Palmer; Ray Chacko; Eduardo Bruera
Journal:  Oncologist       Date:  2011-01-31

2.  Predicting methylphenidate response in long-term survivors of childhood cancer: a randomized, double-blind, placebo-controlled, crossover trial.

Authors:  Heather M Conklin; Susan Helton; Jason Ashford; Raymond K Mulhern; Wilburn E Reddick; Ronald Brown; Melanie Bonner; Bruce W Jasper; Shengjie Wu; Xiaoping Xiong; Raja B Khan
Journal:  J Pediatr Psychol       Date:  2009-05-22

3.  Neuroimaging-Aided Prediction of the Effect of Methylphenidate in Children with Attention-Deficit Hyperactivity Disorder: A Randomized Controlled Trial.

Authors:  Ayaka Ishii-Takahashi; Ryu Takizawa; Yukika Nishimura; Yuki Kawakubo; Kasumi Hamada; Shiho Okuhata; Shingo Kawasaki; Hitoshi Kuwabara; Takafumi Shimada; Ayako Todokoro; Takashi Igarashi; Kei-Ichiro Watanabe; Hidenori Yamasue; Nobumasa Kato; Kiyoto Kasai; Yukiko Kano
Journal:  Neuropsychopharmacology       Date:  2015-05-04       Impact factor: 7.853

Review 4.  Primary Pediatric Care Psychopharmacology: Focus on Medications for ADHD, Depression, and Anxiety.

Authors:  Jeffrey R Strawn; Eric T Dobson; Lisa L Giles
Journal:  Curr Probl Pediatr Adolesc Health Care       Date:  2016-12-30

5.  The impact of individual and methodological factors in the variability of response to methylphenidate in ADHD pharmacogenetic studies from four different continents.

Authors:  Guilherme Polanczyk; Stephen V Faraone; Claiton H D Bau; Marcelo M Victor; Katja Becker; Reta Pelz; Jan K Buitelaar; Barbara Franke; Sandra Kooij; Emma van der Meulen; Keun-Ah Cheon; Eric Mick; Diane Purper-Ouakil; Philip Gorwood; Mark A Stein; Edwin H Cook; Luis Augusto Rohde
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2008-12-05       Impact factor: 3.568

6.  Post Hoc Analysis of Potential Predictors of Response to Atomoxetine for the Treatment of Adults with Attention-Deficit/Hyperactivity Disorder using an Integrated Database.

Authors:  Chris Bushe; Esther Sobanski; David Coghill; Lovisa Berggren; Katrien De Bruyckere; Sami Leppämäki
Journal:  CNS Drugs       Date:  2016-04       Impact factor: 5.749

Review 7.  Pharmacokinetics and clinical effectiveness of methylphenidate.

Authors:  H C Kimko; J T Cross; D R Abernethy
Journal:  Clin Pharmacokinet       Date:  1999-12       Impact factor: 6.447

8.  Effects of maternal symptom ratings and other clinical features on short-term treatment response to OROS methylphenidate in children and adolescents with ADHD in a naturalistic clinical setting.

Authors:  Esra Cop Tasgin; Ozgur Oner; Pinar Yurtbasi; Kerim Munir
Journal:  Klinik Psikofarmakol Bulteni       Date:  2016

9.  Treatment of attention deficit hyperactivity disorder in children. Predictors of treatment outcome.

Authors:  Saskia van der Oord; P J M Prins; J Oosterlaan; P M G Emmelkamp
Journal:  Eur Child Adolesc Psychiatry       Date:  2007-09-14       Impact factor: 4.785

10.  Predictors of treatment response in adolescents with comorbid substance use disorder and attention-deficit/hyperactivity disorder.

Authors:  Leanne Tamm; Kathlene Trello-Rishel; Paula Riggs; Paul A Nakonezny; Michelle Acosta; Genie Bailey; Theresa Winhusen
Journal:  J Subst Abuse Treat       Date:  2012-08-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.